Drug name - Vitekta

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7176220 GILEAD SCIENCES INC 4-oxoquinoline compound and use thereof as pharmaceutical agent
Aug, 2026

(3 years from now)

US7635704 GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound
Oct, 2026

(4 years from now)

US8981103 GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound
Oct, 2026

(4 years from now)

CN100375742C GILEAD SCIENCES INC 4-Oxo-Quinoline Compound And Use Thereof
Jan, 2023

(3 months from now)

CN1692101A GILEAD SCIENCES INC 4-Oxo-Quinoline Compounds And Their Use As Hiv Integrase Inhibitors
Jan, 2023

(3 months from now)

CN1956961A GILEAD SCIENCES INC Stable Crystal Form Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

CN1956961B GILEAD SCIENCES INC 4 Compound Of Stable Crystal
May, 2025

(2 years from now)

IN200401316P4 GILEAD SCIENCES INC 4-Oxoquinoline Compound And Use Thereof As Pharmaceutical Agent
Nov, 2023

(1 year, 1 month from now)

IN245833B GILEAD SCIENCES INC 4-Oxoquinoline Compound As Hiv Integrase Inhibitor
Nov, 2023

(1 year, 1 month from now)

EP1636190B1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP1636190A1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP1564210B9 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A4 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210B1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7176220

(Pediatric)

GILEAD SCIENCES INC 4-oxoquinoline compound and use thereof as pharmaceutical agent Feb, 2027

(4 years from now)

US7635704

(Pediatric)

GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound Apr, 2027

(4 years from now)

US8981103

(Pediatric)

GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound Apr, 2027

(4 years from now)

More Information on Dosage
Strength Dosage Availability
85MG TABLET;ORAL Discontinued
150MG TABLET;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.